PREGNANCY ASSOCIATED BREAST CANCER DIAGNOSTICS
https://doi.org/10.35266/2949-3447-2025-2-9
Abstract
The article examines the diagnostics of pregnancy associated breast cancer. There is an increase in the morbidity of breast cancer among women of reproductive age, which is associated with a later age of childbearing. Pregnancy complicates diagnostics due to physiologic and hormonal changes in the mammary gland. Main diagnostic methods include ultrasound investigation and biopsy. This study presents clinical cases to demonstrate the importance of early detection and a comprehensive treatment approach. Treatment requires a multidisciplinary approach considering both maternal and fetal health.
About the Authors
L. D. Belotserkovtseva
Surgut State University;
Surgut District Clinical Center of Maternity and Childhood Health Care, Surgut
Russian Federation
Russian Federation
Doctor of Sciences (Medicine), Professor, Honored Doctor of Russian Federation, Head of the Department of Obstetrics, Gynaecology and Perinatology, President
N. V. Klimova
Surgut State University;
Surgut District Clinical Center of Maternity and Childhood Health Care, Surgut
Russian Federation
Russian Federation
Doctor of Sciences (Medicine), Professor, Head of Multidisciplinary Clinical Training Department, Head of Radiology Department
A. A, Kuznetsov
Surgut State University;
Surgut District Clinical Center of Maternity and Childhood Health Care, Surgut
Russian Federation
Russian Federation
Candidate of Sciences (Medicine), Senior Lecturer, Radiologist
References
1. Волочаева М. В., Шмаков Р. Г. Беременность и рак молочной железы: тактика ведения беременности, особенности диагностики и лечения // Эффективная фармакотерапия. 2013. № 28. С. 6–9.
2. Sung H., Siegel R. L., Rosenberg P. S. et al. Emerging cancer trends among young adults in the USA: Analysis of a population-based cancer registry // The Lancet. Public Health. 2019. Vol. 4, no. 3. P. E137–E147. https://doi.org/10.1016/s2468-2667(18)30267-6.
3. Иванова О. А., Жильцова Е. К., Иванов В. Г. и др. Рак молочной железы и беременность: особенности диагностики и лечения // Злокачественные опухоли. 2014. № 1. С. 14–18. https://doi.org/10.18027/2224-5057-2014-1-14-18.
4. Загаштокова А. К., Пароконная А. А., Петровский А. В. и др. Рак молочной железы во время беременности: диагностика и лечение. Обзор литературы // Онкогинекология. 2023. № 3. С. 4–16.
5. Чернышова А. Л., Черняков А. А., Горбуков Е. Ю. и др. Сочетание беременности и рака молочной железы // Опухоли женской репродуктивной системы. 2023. Т. 19, № 3. С. 85–91. https://doi.org/10.17650/1994-4098-2023-19-3-85-91.
6. Якушевская О. В., Юренева С. В., Ашрафян Л. А. и др. Контрацепция у пациенток с отягощенным онкологическим анамнезом: рак молочной железы и гинекологический рак (часть I) // Акушерство и гинекология. 2022. № 11. С. 45–51. https://doi.org/10.18565/aig.2022.11.45-51.
7. Andersson T. M.-L., Johansson A. L. V., Hsieh C.-C. et al. Increasing incidence of pregnancy-associated breast cancer in Sweden // Obstetrics & Gynecology. 2009. Vol. 114, no. 3. P. 568–572. https://doi.org/10.1097/AOG.0b013e3181b19154.
8. Gradishar W. J., Moran M. S., Abraham J. et al. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology // Journal of the National Comprehensive Cancer Network. 2024. Vol. 22, no. 5. P. 331–357. https://doi.org/10.6004/jnccn.2024.0035.
9. Doll A., Kapoor N. S. ASO author reflections: First descriptions of patients with pregnancy associated breast cancer and subsequent pregnancy // Annals of Surgical Oncology. 2024. Vol. 31. P. 7547–7548. https://doi.org/10.1245/s10434-024-15854-0.
10. Kieturakis A. J., Wahab R. A., Vijapura C. et al. Current recommendations for breast imaging of the pregnant and lactating patient // American Journal of Roentgenology. 2021. Vol. 216, no. 6. P. 1462–1475. https://doi.org/10.2214/AJR.20.23905.
11. Lambertini M., Blondeaux E., Bruzzone M. et al. Pregnancy after breast cancer: A systematic review and meta-analysis // Journal of Clinical Oncology. 2021. Vol. 39, no. 29. P. 3293–3305. https://doi.org/10.1200/JCO.21.00535.
12. Loibl S., Azim H. A., Bachelot T. et al. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC) // Annals of Oncology. 2023. Vol. 34, no. 10. P. 849–866. https://doi.org/10.1016/j.annonc.2023.08.001.
13. Loibl S., Schmidt A., Gentilini O. et al. Breast cancer diagnosed during pregnancy: Adapting recent advances in breast cancer care for pregnant patients // JAMA Oncology. 2015. Vol. 1, no. 8. P. 1145–1153. https://doi.org/10.1001/jamaoncol.2015.2413.
14. Partridge A., Pagani O., Niman S. M. et al. Abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13) // Cancer Research. 2023. Vol. 83. P. GS4–09. https://doi.org/10.1158/1538-7445. SABCS22-GS4-09.
15. Shao C., Yu Z., Xiao J. et al. Prognosis of pregnancy-associated breast cancer: A meta-analysis // BMC Cancer. 2020. Vol. 20. https://doi.org/10.1186/s12885-020-07248-8.
Review
For citations:
Belotserkovtseva L.D., Klimova N.V., Kuznetsov A.A. PREGNANCY ASSOCIATED BREAST CANCER DIAGNOSTICS. Vestnik SurGU. Meditsina. 2025;18(2):65-72. (In Russ.) https://doi.org/10.35266/2949-3447-2025-2-9
Views:
44
Email this article 
